运动干预对精神病症状网络结构的影响:来自两个临床试验的分析
Kim Laurendeau1, Paquito Bernard2, Florence Piché1,3
1Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal (CRIUSMM), Montréal, Québec, Canada.
Early intervention in psychiatry
|January 8, 2026
概括
运动干预似乎可以减少精神病患者症状的相互联系. 这项研究表明了运动如何通过改变症状网络动态来改善心理健康的潜在机制.
科学领域:
- 精神病学和心理健康 精神病学和心理健康
- 神经科学是一个神经科学.
- 运动科学 运动科学
背景情况:
- 运动在控制精神病症状方面具有公认的好处,但基本机制在很大程度上是未知的.
- 精神病障碍可以被视为复杂的系统,症状在其中动态相互作用.
- 运动干预可以在网络框架内影响这些症状动态.
研究的目的:
- 研究运动干预措施对精神病症状网络连接性的影响.
- 为了比较精神疾病患者运动前后症状的网络结构.
- 探索运动影响精神病症状的潜在机制.
主要方法:
- 来自两项独立的临床试验的综合数据分析,涉及106名被诊断患有精神疾病的参与者.
- 通过半结构面试使用阳性和阴性综合征量表 (PANSS) 评估症状严重程度.
- 进行了网络分析,以比较运动前和运动后的症状结构.
主要成果:
- 基线症状网络密切相互连接,负面症状被确定为最中心的.
- 运动后,症状网络显示密度和连接性降低,连接模式发生变化.
- 在干预前和干预后的网络结构中观察到显著的差异,尽管全球网络的强度保持不变.
结论:
- 这项研究提供了初步证据,表明运动可能会促进精神病症状之间的断开.
- 运动干预可能会改变精神疾病症状网络的动态结构.
- 这些发现表明,运动在治疗精神病方面具有一种新的作用机制,需要进一步研究.
相关概念视频
01:29Psychological and Sociocultural Causes of Schizophrenia
465
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
465
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K
01:26Psychosis: Goals of Pharmacotherapy
460
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
460
01:28Psychosis and Antipsychotic Drugs: Overview
802
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
802
01:28Drug Therapy
239
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
239